In this study, it was found that 149 women (18.4%) developed contralateral breast cancer and that the risk of development considering a period of 15 years after diagnosis was 36.1% for carriers of mutations in the BRCA1 gene and 28.5% for women with BRCA2 gene mutations. This evidence concerns the gene BRCA2 and breast carcinoma.